VPTDF
VENTRIPOINT DIAGNSTCS LTD
stockOTC

VANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- *USANewsGroup.comMarket Intelligence Brief* — **WHAT'S HAPPENING:** The infrastructure holding the global economy together is being stress-tested in real time: * Gold at **$5,552 per ounce** as central banks loaded another **755 tonnes** into reserves \[1\] * The **G7** issued formal guidance treating the quantum threat to current encryption as a **“systemic concern”** \[2\] * The **FDA** cleared a record **295 AI-powered medical devices** in a single calendar year \[3\] * The functional wellness category accelerating toward **$179 billion** as consumers reject legacy formats for precision delivery \[4\] The common thread is structural replacement. Old systems are failing. New ones are being installed. This report profiles five companies positioned at the installation point. **THE ENCRYPTION UPGRADE — CSE: QSE / OTCQB: QSEGF** **Quantum Secure Encryption Corp.** (CSE: QSE) (OTCQB: QSEGF) builds the migration tools enterprises need to survive the quantum transition. The **G7’s** January 2026 guidance made it plain: current encryption is a systemic vulnerability, and organizations that wait will be caught exposed. Earlier this month, **QSE** formalized its three-stage Enterprise Post-Quantum Migration Methodology, delivered through its Quantum Preparedness Assessment platform. The system provides a **post-quantum compliancy dashboard** with risk indicators mapped to compliance frameworks, guided data input workflows, and automated scoring. It integrates alongside existing cybersecurity architectures without wholesale system replacement. The financial and infrastructure sectors are the primary targets. The methodology gives enterprises measurable indicators and visibility into where they stand, turning an abstract threat into a structured remediation plan. **THE GOLD STANDARD — TSX: RUA / OTCQB: NZAUF** **RUA GOLD Inc.** (TSX: RUA) (OTCQB: NZAUF) just uplisted to the Toronto Stock Exchange and closed an oversubscribed **$25 million financing**, giving the company \~**C$38 million** in available cash to drill across two gold projects in New Zealand. The company's recent outlook confirmed four drill rigs operating across the Reefton Goldfield, targeting resource expansion at Auld Creek and new discovery across the historic **2Moz past-producing** district. **RUA** is targeting a Fast-Track mining permit referral in **Q1 2026**, with a regulatory decision expected in Q2. New Zealand just joined the international Minerals Security Partnership, aligning government policy with **RUA’s** development timeline. The Reefton Goldfield carries **gold-antimony** mineralization. Antimony is classified as a critical mineral by multiple governments, adding a strategic dimension to the resource base. An updated NI 43-101 Technical Report is expected by month-end. **THE DIAGNOSTIC SIGNAL — TSXV: VPT / OTCPK: VPTDF** **VentriPoint Diagnostics** (TSXV: VPT) (OTCPK: VPTDF) is commercializing AI-powered cardiac imaging that delivers MRI-grade heart chamber analysis from a standard ultrasound. The **FDA** cleared **VMS+ 4.0** via 510(k) in February 2025, and the company has spent the last twelve months building the commercial infrastructure to scale it. Recently, **VentriPoint** provided a corporate update confirming advancement across multiple fronts: U.S. go-to-market refinement, ongoing distributor alignment in **Europe and the UK**, integration discussions with ASCEND Cardiovascular, collaboration with the Ollie Hinkle Heart Foundation for system placements, and continued work with Lishman Global on **China market entry**. A shareholder videoconference is scheduled for later this month. The 295 AI medical device clearances the FDA issued in 2025 confirm the regulatory environment is open. VentriPoint is building from that cleared position into clinical adoption. **THE DELIVERY MECHANISM — CSE: MOOD / OTCPK: DOSEF** **Doseology Sciences Inc.** (CSE: MOOD) (OTCPK: DOSEF) is building precision oral delivery systems for the functional wellness category. The company appointed Larry Latowsky as Executive Chairman earlier this month. Latowsky previously served as President and CEO of **Katz Group Canada**, the parent of **Rexall-Pharma Plus**, **IDA**, and **Guardian Drug** stores, operating **1,500 pharmacy locations** nationally before a \~**C$3 billion** acquisition by McKesson. In late January, **Doseology** began pilot production of non-nicotine, caffeine-based energy pouches under its Feed That Brain brand. The pouch format delivers measured, portion-controlled energy without sugar, carbonation, or large-volume consumption. A direct-to-consumer launch is expected within weeks. The $179 billion functional beverage rotation is real. **Doseology** is attacking it with a pharmacy-grade governance team and a delivery platform designed for precision, not intensity. **THE TERRITORIAL PLAY — CSE: GGR / OTCQB: GGRFF** **Golden Goose Resources Corp.** (CSE: GGR) (OTCQB: GGRFF) just expanded its investor access by listing on the **OTCQB Venture Market** under the symbol GGRFF. DTC eligibility is pending. The company controls three exploration-stage gold projects across two jurisdictions: the **Gran Esperanza Project** (\~44,000 hectares, Río Negro, Argentina), the **Goldfire Project** (4,680 hectares, Windfall Camp, Quebec, near Gold Fields' Windfall deposit), and the **El Quemado Project** (46 mining concessions, \~58,000 hectares, Salta Province, Argentina). With gold above $5,500, junior explorers with defined land packages in proven districts are the leverage play on the commodity cycle. The OTCQB listing gives U.S. investors a direct line.